Side-by-side comparison of AI visibility scores, market position, and capabilities
Arlington VA global power company (NYSE: AES) at $12.28B 2024 revenue; 32 GW portfolio (50% renewable), Meta solar agreements for AI data centers, 12 GW contracted backlog competing with NextEra for corporate clean energy PPA.
The AES Corporation is an Arlington, Virginia-based global power company — publicly traded on the New York Stock Exchange (NYSE: AES) as an S&P 500 Fortune 500 component — generating and distributing electric power across 15 countries to more than 2.5 million customers worldwide with a generation portfolio totaling over 32 gigawatts, of which renewable energy comprises 50% of capacity. In fiscal year 2024, AES reported revenue of $12.28 billion, completed construction of 3.0 GW of renewable energy projects, and signed 6.8 GW of new contracts, including renewable power purchase agreements for AI data center load growth. AES has earned recognition as the largest global supplier of clean energy to corporations for three consecutive years (BloombergNEF). In 2025, AES signed major solar agreements with Meta for projects in Michigan, Missouri, and Illinois powering hyperscale data centers. AES announced plans to exit coal generation completely by 2025, ahead of its previous target. AES's Fluence joint venture with Siemens is a global leader in energy storage technologies. Founded in 1981 as Applied Energy Services, AES is led by President and CEO Andrés Gluski (since 2011) and employs approximately 10,500 people worldwide.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.